Literature DB >> 11507190

Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution.

S E Kuhmann1, N Madani, O M Diop, E J Platt, J Morvan, M C Müller-Trutwin, F Barré-Sinoussi, D Kabat.   

Abstract

In contrast to humans, several primate species are believed to have harbored simian immunodeficiency viruses (SIVs) since ancient times. In particular, the geographically dispersed species of African green monkeys (AGMs) are all infected with highly diversified SIVagm viruses at high prevalences (greater than 50% of sexually mature individuals) without evident diseases, implying that the progenitor monkeys were infected prior to their dispersal. If this is correct, AGMs would be expected to have accumulated frequent resistance-conferring polymorphisms in host genes that are important for SIV replication. Accordingly, we analyzed the coding sequences of the CCR5 coreceptors from 26 AGMs (52 alleles) in distinct populations of the four species. These samples contained 29 nonsynonymous coding changes and only 15 synonymous nucleotide substitutions, implying intense functional selection. Moreover, 24 of the resulting amino acid substitutions were tightly clustered in the CCR5 amino terminus (D13N in the vervets and Y14N in the tantalus species) or in the first extracellular loop (Q93R and Q93K in all species). The Y14N substitution was extremely frequent in the 12 wild-born African tantalus, with 7 monkeys being homozygous for this substitution and 4 being heterozygous. Although two of these heterozygotes and the only wild-type homozygote were naturally infected with SIVagm, none of the Y14N homozygotes were naturally infected. A focal infectivity assay for SIVagm indicated that all five tested SIVagms efficiently use CCR5 as a coreceptor and that they also use CXCR6 (STRL33/Bonzo) and GPR15 (BOB) with lower efficiencies but not CXCR4. Interestingly, the D13N, Y14N, Q93R, and Q93K substitutions in AGM CCR5 all strongly inhibited infections by the SIVagm isolates in vitro. The Y14N substitution eliminates a tyrosine sulfation site that is important for infections and results in partial N-linked glycosylation (i.e., 60% efficiency) at this position. Nevertheless, the CCR5(Y14N) component that lacks an N-linked oligosaccharide binds the chemokine MIP-lbeta with a normal affinity and is fully active in signal transduction. Similarly, D13N and Q93R substitutions did not interfere with signal transduction. Thus, the common substitution polymorphisms in AGM CCR5 strongly inhibit SIVagm infections while substantially preserving chemokine signaling. In contrast, polymorphisms of human CCR5 are relatively infrequent, and the amino acid substitutions are randomly situated and generally without effects on coreceptor function. These results support an ancient coevolution of AGMs and SIVagm viruses and establish AGMs as a highly informative model for learning about host proteins that play critical roles in immunodeficiency virus infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507190      PMCID: PMC115090          DOI: 10.1128/jvi.75.18.8449-8460.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains.

Authors:  A L Edinger; C Blanpain; K J Kunstman; S M Wolinsky; M Parmentier; R W Doms
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Multiple nonfunctional alleles of CCR5 are frequent in various human populations.

Authors:  C Blanpain; B Lee; M Tackoen; B Puffer; A Boom; F Libert; M Sharron; V Wittamer; G Vassart; R W Doms; M Parmentier
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

3.  Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.

Authors:  B Lee; M Sharron; L J Montaner; D Weissman; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area.

Authors:  S Corbet; M C Müller-Trutwin; P Versmisse; S Delarue; A Ayouba; J Lewis; S Brunak; P Martin; F Brun-Vezinet; F Simon; F Barre-Sinoussi; P Mauclere
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus.

Authors:  S Mummidi; M Bamshad; S S Ahuja; E Gonzalez; P M Feuillet; K Begum; M C Galvis; V Kostecki; A J Valente; K K Murthy; L Haro; M J Dolan; J S Allan; S K Ahuja
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

6.  High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys.

Authors:  O M Diop; A Gueye; M Dias-Tavares; C Kornfeld; A Faye; P Ave; M Huerre; S Corbet; F Barre-Sinoussi; M C Müller-Trutwin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Use of chemokine receptors by poxviruses.

Authors:  A S Lalani; J Masters; W Zeng; J Barrett; R Pannu; H Everett; C W Arendt; G McFadden
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

8.  The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Authors:  N L Michael; G Chang; L G Louie; J R Mascola; D Dondero; D L Birx; H W Sheppard
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

9.  A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.

Authors:  L G Kostrikis; A U Neumann; B Thomson; B T Korber; P McHardy; R Karanicolas; L Deutsch; Y Huang; J F Lew; K McIntosh; H Pollack; W Borkowsky; H M Spiegel; P Palumbo; J Oleske; A Bardeguez; K Luzuriaga; J Sullivan; S M Wolinsky; R A Koup; D D Ho; J P Moore
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

10.  Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1.

Authors:  S E Kuhmann; E J Platt; S L Kozak; D Kabat
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

View more
  20 in total

Review 1.  Systems biology of the vervet monkey.

Authors:  Anna J Jasinska; Christopher A Schmitt; Susan K Service; Rita M Cantor; Ken Dewar; James D Jentsch; Jay R Kaplan; Trudy R Turner; Wesley C Warren; George M Weinstock; Roger P Woods; Nelson B Freimer
Journal:  ILAR J       Date:  2013

2.  Increased inherent intestinal granzyme B expression may be associated with SIV pathogenesis in Asian non-human primates.

Authors:  A T Hutchison; J E Schmitz; C J Miller; K J Sastry; P N Nehete; A M Major; A A Ansari; N Tatevian; D E Lewis
Journal:  J Med Primatol       Date:  2011-07-07       Impact factor: 0.667

3.  Comparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T-cell dynamics in vervet and sabaeus African green monkeys.

Authors:  Simoy Goldstein; Charles R Brown; Ilnour Ourmanov; Ivona Pandrea; Alicia Buckler-White; Christopher Erb; Jayashree S Nandi; Gabriel J Foster; Patrick Autissier; Jörn E Schmitz; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.

Authors:  Katherine S Wetzel; Yanjie Yi; Sarah T C Elliott; Dino Romero; Beatrice Jacquelin; Beatrice H Hahn; Michaela Muller-Trutwin; Cristian Apetrei; Ivona Pandrea; Ronald G Collman
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys.

Authors:  Ivona Pandrea; Christopher Kornfeld; Mickael J-Y Ploquin; Cristian Apetrei; Abdourahmane Faye; Pierre Rouquet; Pierre Roques; François Simon; Françoise Barré-Sinoussi; Michaela C Müller-Trutwin; Ousmane M Diop
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors.

Authors:  Nadeene E Riddick; Fan Wu; Kenta Matsuda; Sonya Whitted; Ilnour Ourmanov; Simoy Goldstein; Robert M Goeken; Ronald J Plishka; Alicia Buckler-White; Jason M Brenchley; Vanessa M Hirsch
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

Review 7.  HIV-associated chronic immune activation.

Authors:  Mirko Paiardini; Michaela Müller-Trutwin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 8.  Host gene evolution traces the evolutionary history of ancient primate lentiviruses.

Authors:  Alex A Compton; Harmit S Malik; Michael Emerman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-08-12       Impact factor: 6.237

9.  Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild.

Authors:  Dongzhu Ma; Anna J Jasinska; Felix Feyertag; Viskam Wijewardana; Jan Kristoff; Tianyu He; Kevin Raehtz; Christopher A Schmitt; Yoon Jung; Jennifer Danzy Cramer; Michel Dione; Martin Antonio; Russell Tracy; Trudy Turner; David L Robertson; Ivona Pandrea; Nelson Freimer; Cristian Apetrei
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

10.  DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm.

Authors:  Mickaël J-Y Ploquin; Ousmane M Diop; Nathalie Sol-Foulon; Lorenzo Mortara; Abdourahmane Faye; Marcelo A Soares; Eric Nerrienet; Roger Le Grand; Yvette Van Kooyk; Ali Amara; Olivier Schwartz; Françoise Barré-Sinoussi; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.